Robustness testing of a tablet formulation using multivariate design

被引:12
作者
Gabrielsson, J
Sjöström, M
Lindberg, NO
Pihl, AC
Lundstedt, T
机构
[1] Uppsala Univ, Dept Med Chem, S-75123 Uppsala, Sweden
[2] Umea Univ, Dept Chem, Chemometr Res Grp, Umea, Sweden
[3] Pharmacia AB, Consumer Healthcare, Helsingborg, Sweden
关键词
robustness testing; Plackett-Burman design; multivariate design; PCA; PLS;
D O I
10.1080/03639040500518823
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A total of 45 experiments were carried out to evaluate the robustness of two similar tablet formulations - a product of two strengths - with respect to normal batch-to-batch variation of the excipients and the active pharmaceutical ingredient. The formulations consist of 10 ingredients. Because of the differing amounts of active pharmaceutical ingredients, the two formulations also differ in the amounts of two of the diluents and one of the binders. The excipients and active pharmaceutical ingredient were characterized in terms of multiple variables, and principal properties were calculated with principal component analysis. A Plackett and Burman design was applied to the principal properties. The relationships between the design factors and two responses, mean disintegration time and mean crushing strength, were evaluated by using regression methods. Both formulations were found to be robust under controlled conditions.
引用
收藏
页码:297 / 307
页数:11
相关论文
共 10 条
[1]   Functionality related tests for excipients [J].
Armstrong, NA .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 155 (01) :1-5
[2]   STANDARD NORMAL VARIATE TRANSFORMATION AND DE-TRENDING OF NEAR-INFRARED DIFFUSE REFLECTANCE SPECTRA [J].
BARNES, RJ ;
DHANOA, MS ;
LISTER, SJ .
APPLIED SPECTROSCOPY, 1989, 43 (05) :772-777
[3]  
Box G. E., 1978, Statistics for experimenters: An introduction to design, data analysis, and model building
[4]  
Eriksson L., 2000, DESIGN EXPT PRINCIPL
[5]   Multivariate methods in the development of a new tablet formulation [J].
Gabrielsson, J ;
Lindberg, NO ;
Pålsson, M ;
Nicklasson, F ;
Sjöström, M ;
Lundstedt, T .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2003, 29 (10) :1053-1075
[6]  
PLACKETT RL, 1946, BIOMETRIKA 4, V33, P305, DOI [DOI 10.2307/2332195, DOI 10.1093/BIOMET/33.4.305]
[7]  
Wade A., 1994, HDB PHARM EXCIPIENTS
[8]  
Walking WD., 1994, HDB PHARM EXCIPIENTS, P392
[9]   PRINCIPAL COMPONENT ANALYSIS [J].
WOLD, S ;
ESBENSEN, K ;
GELADI, P .
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 1987, 2 (1-3) :37-52
[10]   MULTIVARIATE DESIGN [J].
WOLD, S ;
SJOSTROM, M ;
CARLSON, R ;
LUNDSTEDT, T ;
HELLBERG, S ;
SKAGERBERG, B ;
WIKSTROM, C ;
OHMAN, J .
ANALYTICA CHIMICA ACTA, 1986, 191 :17-32